aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in...
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in...
News summary: Service provider received federal funding to enhance digital inclusion with high-quality internet for underserved Native American tribal regions...
Eduardo Iniguez, former Silvus Technologies’ CFO, appointed CEO Jason Mudrick, Mudrick Capital’s Founder and CIO, appointed Chair of the Board...
NEW HAVEN, Conn., Feb. 28, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy...
ANNISTON, Ala. and CARTERSVILLE, Ga., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Southern States Bancshares, Inc. (NASDAQ: SSBK) (“Southern States”), the...
- Updated dose escalation data from SNS-101 clinical study supports favorable and potentially best-in-class safety and PK profile both as...
Third consecutive year of 30%+ revenue growth since going public in 2021 Significantly expanded profitability in 2023 Contacts Investors: Michelle...
Full year revenue reached $235.5 million, representing 36% YoY growth; recurring revenue up 44% YoYRead more at globenewswire.com
Full Year 2023 Highlights: NEW YORK, Feb. 28, 2024 /PRNewswire/ -- Lindblad Expeditions Holdings, Inc. (NASDAQ: LIND; the "Company" or...
– ARCALYST® (rilonacept) Q4 2023 and full-year 2023 net product revenue of $71.2 million and $233.2 million, respectively –– ARCALYST...
Immunocore reports fourth quarter and full year 2023 financial results and provides a business updateKIMMTRAK (tebentafusp) net revenues of $67.6...
DENVER, Colo., Feb 28, 2024 (247marketnews.com)- Bit Brother Limited (NASDQ:BETS) is trading at $4.03, up $1.54 (+61.85%), on 6.49M shares,...
BOSTON, Feb. 28, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and...
BROOKINGS, S.D., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Daktronics, Inc. (NASDAQ-DAKT), a leading global designer and manufacturer of best-in-class dynamic...
SOUTH SAN FRANCISCO, Calif., and ALBANY, Ga., and WASHINGTON, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK), together...
CELEBRATION, Fla., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company,...
EMERYVILLE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of...
EMERYVILLE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of...
EMERYVILLE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of...
TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a digital...
BOCA RATON, Fla., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF),...
TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced today that it expects...
VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or...
CAMBRIDGE, MA / ACCESSWIRE / February 28, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced its participation in the following upcoming...
Contacts Tokens.com Corp. Andrew Kiguel, CEO Email: contact@tokens.com Jennifer Karkula, Head of Communications Email: contact@tokens.com Tokens.com Corp. (Cboe Canada: COIN)...
Please find enclosed the presentation of Golden Ocean Group Limited’s fourth quarter 2023 results for today’s webcast / conference call...
FORT WORTH, Texas, Feb. 28, 2024 (GLOBE NEWSWIRE) -- To meet the growing demand for cost-effective vocational evaluation services in...
MINNEAPOLIS, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies...
LONDON, UK / ACCESSWIRE / February 28, 2024 / Golden Metal Resources plc ("Golden Metal" or the "Company") (LSE:GMET)(OTCQB:GMTLF), a...
NEW YORK and SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...
Contacts Investor Contact Allison Wey Senior Vice President, Investor Relations and Corporate Communications awey@xerispharma.com Xeris Biopharma Holdings, Inc. (Nasdaq: XERS),...
NEW YORK, Feb. 28, 2024 /PRNewswire/ -- Travelzoo® (NASDAQ: TZOO): Travelzoo, the club for travel enthusiasts, today announced financial results...
Germany’s De-Scheduling of Cannabis Opens Path to New Opportunities for Tilray in Potential $3bn Medical MarketEuropean Union Medical Cannabis Market...
Fourth quarter and full year 2023 BRIUMVI U.S. net revenue of approximately $40 million and $89 million, respectivelyConference call to...
BANNOCKBURN, Ill., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq: SRCL) today reported results for the fourth quarter ended December 31,...
AUSTIN, Texas, Feb. 28, 2024 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a...
LONG ISLAND CITY, N.Y., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Steve Madden (Nasdaq: SHOO), a leading designer and marketer of...
Contacts Repare: Robin Garner Vice President and Head of Investor Relations Repare Therapeutics Inc. investor@reparerx.com Investors: Matthew DeYoung Argot Partners...
Contacts Investor Relations Contact Dean Pohl Rimini Street, Inc. +1 925 523-7636 dpohl@riministreet.com Media Relations Contact Janet Ravin Rimini Street,...